Exclusive

Publication

Byline

Trump's planned drug price cuts trigger decline in share prices: Will Indian pharma be impacted?

New Delhi, May 12 -- Shares of Indian pharmaceutical companies plunged close to 6% on Monday after US President Donald Trump proposed sweeping price cuts on prescription drugs and pharma prices in the... Read More


Dr. Reddy's focused on securing supply chains amid US tariff uncertainty

New Delhi, May 9 -- Amid growing concerns about potential US import tariffs on pharmaceuticals, Indian generics giant Dr. Reddy's Laboratories is taking steps to secure its supply chain for key produc... Read More


Bain Capital-owned Indian chemicals firm eyes US expansion after key acquisition

New Delhi, May 8 -- Novopor Advanced Science Pvt. Ltd, a Bain Capital portfolio company manufacturing specialty chemicals, is looking to expand its footprint in the US after chalking up its first acqu... Read More


Bain Capital-backed Indian chemicals firm eyes US expansion after key acquisition

New Delhi, May 8 -- Novopor Advanced Science Pvt. Ltd, a Bain Capital portfolio company manufacturing specialty chemicals, is looking to expand its footprint in the US after chalking up its first acqu... Read More


TPG acquires 35% stake in Schott Pharma from Serum Institute

New Delhi, May 6 -- US private equity firm TPG has entered into a binding agreement to acquire a 35% stake in the SCHOTT Poonawalla joint venture from Serum Institute of India (SII), the firms announc... Read More


Healthify shifts gears to incorporate weight-loss drugs, cash in on anti-obesity boom

New Delhi, May 1 -- Nutrition-tracking platform Healthify is banking on weight-loss drugs to boost growth, anticipating demand for these medicines to boom in India. The company is increasing its offe... Read More


We need to build, build, build: Max Healthcare CMD Soi

New Delhi, April 29 -- Max Healthcare is focusing on building capacity this year, with over 1,300 beds planned to be added across its hospitals by December. The hospital chain is aiming to increase it... Read More


US generics, domestic market to drive healthy sales growth for pharma companies in Q4

New Delhi, April 28 -- Pharma companies are expected to report healthy revenue growth of 11-13% in the fourth quarter of FY25, driven by strong traction in niche US generic drugs, steady domestic perf... Read More


Hospital chains to report steady growth in Q4, but there are challenges

New Delhi, April 25 -- Hospital chains are expected to report steady growth in the fourth quarter of FY25 (Q4FY25), driven by an increase in bed additions and higher revenue per bed, analysts said. Th... Read More


Demand for weight loss drugs is growing. Can wellness companies keep up?

New Delhi, April 17 -- US pharmaceutical company Eli Lilly launched its once-a-week weight loss injection Mounjaro in India last month, reigniting interest in weight loss solutions, this time with a m... Read More